AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

Recruitingn/aAges 18 Years - anyAllCamurus AB
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Have started or will be starting treatment with octreotide SC depot for acromegaly Exclusion Criteria: * Have started or will be starting treatment with octreotide SC depot for other conditions not related to acromegaly * Currently taking part in an interventional clinical trial or is still within a 30-day washout period from the end of taking part in an interventional clinical trial.
💊

What it tests

  • Octreotide subcutaneous depot
📍

Where

6 sites
Universitaetsklinikum Aachen
Aachen, Germany
Universitaetsklinikum Leipzig
Leipzig, Germany
Fachpraxis für Innere Medizin, Endokrinologie und Diabetologie
Magdeburg, Germany
Medicover Neuroendokrinologie MVZ
München, Germany
Universitätsklinikum Würzburg
Würzburg, Germany
St James's University Hospital - Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy